Q4 2025 Net Sales: $693 million, a 3.9% increase from Q4 2024. Q4 2025 Gross Margin: 49.8% GAAP, 52.5% non-GAAP. Q4 2025 Operating Loss: $119 million, including $173 million in impairment charges. Q4 ...
Bio-Rad Laboratories Inc. reports fourth-quarter results Thursday after market close, with investors looking to see whether the life sciences tools maker can sustain momentum from a strong prior ...
More than 100 researchers call for safeguards on high-risk biological datasets to prevent AI misuse, which could create deadly pathogens. Artificial intelligence (AI) models for biology rely heavily ...
Fujifilm Biotechnologies celebrated the grand opening of its expanded site in Teesside, U.K. Funded through a total investment of approximately £400m ($545m) from Fujifilm Corp., Japan, the expansion ...
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results